OCX · Categories · Form 4

OCX - SEC Form 4 insider transactions

Oncocyte Corporation (OCX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for OCX

• 341d
  Director Arno Andrew was granted 55,000 shares, increasing direct ownership by 67% to 136,554 units (SEC Form 4)

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 341d
  Director Silverman Lou was granted 35,000 shares, increasing direct ownership by 2,238% to 36,564 units (SEC Form 4)

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 341d
  Director Last Andrew J. was granted 35,000 shares, increasing direct ownership by 776% to 39,509 units (SEC Form 4)

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 438d
  SEC Form 4 filed by Chief Financial Officer James Andrea S.

  4 - Oncocyte Corp (0001642380) (Issuer)
• 438d
  SEC Form 4 filed by VP ACCT, Cntlr, Treasurer, PAO Liu James Yang

  4 - Oncocyte Corp (0001642380) (Issuer)
• 438d
  SEC Form 4 filed by CEO and President Riggs Josh

  4 - Oncocyte Corp (0001642380) (Issuer)
• 602d
  SEC Form 4 filed by Chief Financial Officer James Andrea S.

  4 - Oncocyte Corp (0001642380) (Issuer)
• 705d
  SEC Form 4 filed by Director Silverman Lou

  4 - Oncocyte Corp (0001642380) (Issuer)
• 705d
  SEC Form 4 filed by Director Arno Andrew

  4 - Oncocyte Corp (0001642380) (Issuer)
• 705d
  SEC Form 4 filed by Director Last Andrew J.

  4 - Oncocyte Corp (0001642380) (Issuer)
• 715d
  SEC Form 4 filed by Chief Financial Officer James Andrea S.

  4 - Oncocyte Corp (0001642380) (Issuer)
• 748d
  SEC Form 4 filed by Liu James Yang

  4 - Oncocyte Corp (0001642380) (Issuer)
• 748d
  SEC Form 4 filed by Arno Andrew

  4 - Oncocyte Corp (0001642380) (Issuer)
• 748d
  SEC Form 4 filed by Riggs Josh

  4 - Oncocyte Corp (0001642380) (Issuer)
• 971d
  SEC Form 4 filed by Liu James Yang

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1027d
  SEC Form 4 filed by Riggs Josh

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1072d
  SEC Form 4 filed by Gutfreund John Peter

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1077d
  SEC Form 4 filed by Last Andrew J.

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1077d
  SEC Form 4 filed by Arno Andrew

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1077d
  SEC Form 4 filed by Kingsley Alfred D

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1077d
  SEC Form 4 filed by Silverman Lou

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1089d
  SEC Form 4 filed by Kingsley Alfred D

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1092d
  SEC Form 4 filed by Riggs Josh

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1148d
  SEC Form 4 filed by Pura Vida Investments, Llc

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1148d
  SEC Form 4 filed by Pura Vida Investments, Llc (Amendment)

  4/A - Oncocyte Corp (0001642380) (Issuer)
• 1159d
  SEC Form 4 filed by Pura Vida Investments, Llc

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1160d
  SEC Form 4 filed by Broadwood Partners, L.P.

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1160d
  SEC Form 4 filed by Gutfreund John Peter

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1160d
  SEC Form 4 filed by Arno Andrew

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1188d
  SEC Form 4: Pura Vida Investments, Llc disposed of 3,890,111 shares

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1197d
  SEC Form 4 filed by John Anish M.

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1197d
  SEC Form 4 filed by Riggs Josh

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1237d
  SEC Form 4 filed by Riggs Josh

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1237d
  SEC Form 4 filed by Liu James Yang

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1237d
  SEC Form 4 filed by John Anish M.

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1259d
  SEC Form 4: Arno Andrew bought $87,875 worth of shares (250,000 units at $0.35), increasing direct ownership by 89% to 532,049 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1259d
  SEC Form 4: Gutfreund John Peter bought $24,728 worth of shares (75,000 units at $0.33)

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1260d
  SEC Form 4: Kingsley Alfred D bought $7,125 worth of shares (25,000 units at $0.28), increasing direct ownership by 6% to 439,111 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1264d
  SEC Form 4: Ross Douglas T. was granted 213,797 shares, increasing direct ownership by 1,052% to 234,114 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1267d
  SEC Form 4: Paulsen Gisela returned 175,000 shares to the company, decreasing direct ownership by 32% to 366,500 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1267d
  SEC Form 4: Ross Douglas T. returned 150,000 shares to the company, decreasing direct ownership by 88% to 20,317 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1277d
  SEC Form 4: Andrews Ronald Asbury converted options into 250,000 shares, increasing direct ownership by 75% to 583,212 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1390d
  SEC Form 4: Arno Andrew bought $13,500 worth of shares (15,000 units at $0.90)

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1390d
  SEC Form 4: Last Andrew J. bought $17,400 worth of shares (20,000 units at $0.87), increasing direct ownership by 40% to 70,170 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: Andrews Ronald Asbury bought $38,400 worth of shares (40,000 units at $0.96), increasing direct ownership by 14% to 333,212 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: Ross Douglas T. was granted 150,000 shares, increasing direct ownership by 738% to 170,317 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: Paulsen Gisela was granted 525,000 shares, increasing direct ownership by 3,182% to 541,500 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: Last Andrew J. was granted 10,000 shares, increasing direct ownership by 25% to 50,170 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: Kingsley Alfred D bought $9,700 worth of shares (10,000 units at $0.97) and was granted 10,000 shares, increasing direct ownership by 5% to 414,111 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: Gutfreund John Peter was granted 10,000 shares and bought $23,250 worth of shares (25,000 units at $0.93)

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: John Anish M. was granted 150,000 shares

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: Griffith Melinda was granted 10,000 shares and bought $10,000 worth of shares (10,000 units at $1.00), increasing direct ownership by 200% to 30,000 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: Carter Jennifer L. was granted 10,000 shares and bought $9,975 worth of shares (10,500 units at $0.95), increasing direct ownership by 205% to 30,500 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1391d
  SEC Form 4: Arno Andrew was granted 10,000 shares and bought $144,121 worth of shares (150,000 units at $0.96), increasing direct ownership by 131% to 282,049 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1421d
  SEC Form 4: Griffith Melinda converted options into 10,000 shares

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1421d
  SEC Form 4: Redmond Cavan M. converted options into 10,000 shares, increasing direct ownership by 9% to 120,863 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1421d
  SEC Form 4: Kingsley Alfred D converted options into 10,000 shares, increasing direct ownership by 3% to 394,111 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1421d
  SEC Form 4: Carter Jennifer L. converted options into 10,000 shares

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1421d
  SEC Form 4: Last Andrew J. converted options into 10,000 shares, increasing direct ownership by 33% to 40,170 units

  4 - Oncocyte Corp (0001642380) (Issuer)
• 1421d
  SEC Form 4: Arno Andrew converted options into 10,000 shares, increasing direct ownership by 9% to 122,049 units

  4 - Oncocyte Corp (0001642380) (Issuer)

Other OCX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends